Your browser doesn't support javascript.
loading
Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs.
Hata, Tomomi; Nakamura, Kenichi; Yonemori, Kan; Noguchi, Emi; Watanabe, Makiko; Sohn, Joohyuk; Lu, Yen-Shen; Yap, Yoon-Sim; Tamura, Kenji; Fujiwara, Yasuhiro.
Afiliación
  • Hata T; International Trial Management Section, Research Management Division, Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan.
  • Nakamura K; Research Management Division, Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan.
  • Yonemori K; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Noguchi E; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Watanabe M; International Trial Management Section, Research Management Division, Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan.
  • Sohn J; Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • Lu YS; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Yap YS; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Tamura K; Innovative Cancer Center, Shimane University Hospital, Izumo, Japan.
  • Fujiwara Y; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Clin Transl Sci ; 14(3): 1015-1025, 2021 05.
Article en En | MEDLINE | ID: mdl-33382914

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Drogas en Investigación / Aprobación de Drogas / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Clin Transl Sci Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Drogas en Investigación / Aprobación de Drogas / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Clin Transl Sci Año: 2021 Tipo del documento: Article País de afiliación: Japón